BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8203685)

  • 1. The use of nonoxynol-9 for protection against cervical gonorrhea.
    Weir SS; Feldblum PJ; Zekeng L; Roddy RE
    Am J Public Health; 1994 Jun; 84(6):910-4. PubMed ID: 8203685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
    Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Weir SS; Wong EL
    N Engl J Med; 1998 Aug; 339(8):504-10. PubMed ID: 9709043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonorrhea as a risk factor for HIV acquisition.
    Weir SS; Feldblum PJ; Roddy RE; Zekeng L
    AIDS; 1994 Nov; 8(11):1605-8. PubMed ID: 7848598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections.
    Niruthisard S; Roddy RE; Chutivongse S
    Lancet; 1992 Jun; 339(8806):1371-5. PubMed ID: 1350804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barrier contraceptive use and HIV infection among high-risk women in Cameroon.
    Zekeng L; Feldblum PJ; Oliver RM; Kaptue L
    AIDS; 1993 May; 7(5):725-31. PubMed ID: 8391273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonoxynol-9 use, genital ulcers, and HIV infection in a cohort of sex workers.
    Weir SS; Roddy RE; Zekeng L; Feldblum PJ
    Genitourin Med; 1995 Apr; 71(2):78-81. PubMed ID: 7744418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nonoxynol-9 gel on urogenital gonorrhea and chlamydial infection: a randomized controlled trial.
    Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Tweedy KG
    JAMA; 2002 Mar; 287(9):1117-22. PubMed ID: 11879108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia.
    Hira SK; Feldblum PJ; Kamanga J; Mukelabai G; Weir SS; Thomas JC
    Int J STD AIDS; 1997 Apr; 8(4):243-50. PubMed ID: 9147157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FHI study examines N-9 film effect on STDs. Contraceptive update.
    Netw Res Triangle Park N C; 1997; 17(3):4-5. PubMed ID: 12292394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update: barrier protection against HIV infection and other sexually transmitted diseases.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Aug; 42(30):589-91, 597. PubMed ID: 8336689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No added STD protection from spermicidal condoms.
    Contracept Technol Update; 1998 Aug; 19(8):105-6. PubMed ID: 12348577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Views of Cameroonian sex workers on a woman-controlled method of contraception and disease protection.
    Visness CM; Ulin P; Pfannenschmidt S; Zekeng L
    Int J STD AIDS; 1998 Nov; 9(11):695-9. PubMed ID: 9863584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial comparing nonoxynol-9 lubricated condoms with silicone lubricated condoms for prophylaxis.
    Roddy RE; Cordero M; Ryan KA; Figueroa J
    Sex Transm Infect; 1998 Apr; 74(2):116-9. PubMed ID: 9634323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-9 film study a blow for microbicide research.
    AIDS Alert; 1997 Jun; 12(6):66-8. PubMed ID: 11364359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barrier methods may offer some protection against AIDS.
    Netw Res Triangle Park N C; 1987; (Spec No):8. PubMed ID: 12281265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective effect of condoms and nonoxynol-9 against HIV infection.
    Wittkowski KM; Susser E; Dietz K
    Am J Public Health; 1998 Apr; 88(4):590-6. PubMed ID: 9551000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Ideal' microbicide may be best form of protection.
    AIDS Alert; 1999 Feb; 14(2):suppl 3-4. PubMed ID: 11366179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WHO/CONRAD technical consultation on nonoxynol-9, World Health Organization, Geneva, 9-10 October 2001: summary report.
    World Health Organization
    Reprod Health Matters; 2002 Nov; 10(20):175-81. PubMed ID: 12569895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers. COL-1492 Phase II Study Group.
    Van Damme L; Chandeying V; Ramjee G; Rees H; Sirivongrangson P; Laga M; Perriëns J
    AIDS; 2000 Jan; 14(1):85-8. PubMed ID: 10714571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial.
    Richardson BA; Lavreys L; Martin HL; Stevens CE; Ngugi E; Mandaliya K; Bwayo J; Ndinya-Achola J; Kreiss JK
    Sex Transm Dis; 2001 Jul; 28(7):394-400. PubMed ID: 11460023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.